The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis — Anne‐Sophie Michallet (2022) | RDL Network
The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis
Article 2022 en
Authors
AM
Anne‐Sophie Michallet
SM
Stephanie Malartre
EV
Elodie Vignaud
Abstract
1 min read
The AMA programme was shown to be cost-effective compared to a simulated control arm with no intervention.
Marco Proietti, Alessio Farcomeni, Peter Goethals, Christophe Scavée, Johan Vijgen, Ivan Blankoff, Yves Vandekerckhove, Professor Gregory Lip, Georges H. Mairesse
Elizabeth A. Magnuson, Khaja Chinnakondepalli, Katherine Vilain, Patrick W. Serruys, Joseph F. Sabik, A. Pieter Kappetein, Gregg W. Stone, David J. Cohen
Discussion(0)
No comments yet. Be the first to comment.